Literature DB >> 14568572

Comparative studies on the regulation of insulin-like growth factor-binding protein-1 (IGFBP-1) and sex hormone-binding globulin (SHBG) production by insulin and insulin-like growth factors in human hepatoma cells.

T Kalme1, H Koistinen, M Loukovaara, R Koistinen, P Leinonen.   

Abstract

Production of insulin-like growth factor-binding protein-1 (IGFBP-1) by the liver is efficiently inhibited by insulin both in vivo and in vitro. Consequently, serum IGFBP-1 concentration reflects insulin bioactivity in portal vein. Sex hormone-binding globulin (SHBG) is another insulin-regulated liver-derived protein that has appeared promising in detecting individuals with portal hyperinsulinemia. We compared the regulation of IGFBP-1 and SHBG production by insulin and insulin-like growth factors (IGF-I and IGF-II) in human hepatoma cell cultures. Insulin equipotently inhibited IGFBP-1 and SHBG production, with maximal decrease in culture medium concentrations being about 35% for both proteins during 48 h of culture in serum-free medium. IGF-I and IGF-II also inhibited the IGFBP-1 and SHBG levels. We conclude that IGFBP-1 and SHBG are equally sensitive to ambient insulin concentrations in human hepatoma cell cultures, and the production of both proteins is also attenuated by the IGFs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568572     DOI: 10.1016/s0960-0760(03)00268-1

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  9 in total

1.  Pubertal height gain is inversely related to peak BMI in childhood.

Authors:  Anton Holmgren; Aimon Niklasson; Andreas F M Nierop; Lars Gelander; A Stefan Aronson; Agneta Sjöberg; Lauren Lissner; Kerstin Albertsson-Wikland
Journal:  Pediatr Res       Date:  2016-11-18       Impact factor: 3.756

2.  Erectile Dysfunction and Low Sex Drive in Men with Type 2 DM: The Potential Role of Diabetic Pharmacotherapy.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  J Clin Diagn Res       Date:  2016-12-01

3.  Several anthropometric measurements and breast cancer risk: results of the E3N cohort study.

Authors:  B Tehard; F Clavel-Chapelon
Journal:  Int J Obes (Lond)       Date:  2006-01       Impact factor: 5.095

4.  Sex hormone-binding globulin and risk of type 2 diabetes in women and men.

Authors:  Eric L Ding; Yiqing Song; JoAnn E Manson; David J Hunter; Cathy C Lee; Nader Rifai; Julie E Buring; J Michael Gaziano; Simin Liu
Journal:  N Engl J Med       Date:  2009-08-05       Impact factor: 91.245

Review 5.  Endothelial function in pre-pubertal children at risk of developing cardiomyopathy: a new frontier.

Authors:  Aline Cristina Tavares; Edimar Alcides Bocchi; Guilherme Veiga Guimarães
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

6.  Cross-Sectional Associations between Body Size, Circulating Sex-Steroid Hormones and IGF Components among Healthy Chinese Women.

Authors:  Lauren E McCullough; Erline E Miller; Qiong Wang; Jia-Yuan Li; Li Liu; Hui Li; Jing Zhang; Jennifer S Smith
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

7.  Effects of sulfonylurea as initial treatment on testosterone of middle-aged men with type 2 diabetes: A 16-week, pilot study.

Authors:  Long Wong; Hong-Mei Chen; Shui-Qing Lai; Hua-Zhang Yang; Jian Kuang; Jian-Hao Pei
Journal:  J Diabetes Investig       Date:  2015-01-16       Impact factor: 4.232

Review 8.  Poly Cystic Ovarian Syndrome: An Updated Overview.

Authors:  Samer El Hayek; Lynn Bitar; Layal H Hamdar; Fadi G Mirza; Georges Daoud
Journal:  Front Physiol       Date:  2016-04-05       Impact factor: 4.566

9.  Sex Hormone-Binding Globulin Levels Are Inversely Associated With Nonalcoholic Fatty Liver Disease in HIV-Infected and -Uninfected Men.

Authors:  Jennifer C Price; Ruibin Wang; Eric C Seaberg; Todd T Brown; Matthew J Budoff; Lawrence A Kingsley; Frank J Palella; Mallory D Witt; Wendy S Post; Jordan E Lake; Chloe L Thio
Journal:  Open Forum Infect Dis       Date:  2019-11-06       Impact factor: 3.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.